Genital Diseases, Female  >>  gepotidacin (GSK2140944)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
gepotidacin (GSK2140944) / GSK
NCT02294682: A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae

Completed
2
106
US, Europe
GSK2140944
GlaxoSmithKline
Gonorrhea
07/16
07/16

Download Options